Zerbaxa
FDA approves new indication for MSD’s Zerbaxa
June 5, 2019Research and Development Merck, Zerbaxa, bacterial infection, pharma
The FDA has approved US firm Merck’s Zerbaxa (ceftolozane and tazobactam) for adults with hospital-acquired bacterial pneumonia and ventilator-associated bacterial …
Cubist boosts antibiotics market presence
December 22, 2014Sales and Marketing Antibiotics, Zerbaxa, antimicrobial resistance, bacteria, cubist, infections, infectious diseases
Cubist has followed-up its successful European approval for a new antibiotic by winning an endorsement by the US FDA. The …
Latest content
MedPharm appoints Jason Mieding as chief operating officer
November 8, 2026
Coriolis Pharma appoints Teun van der Heide as CEO
November 7, 2026
